Attending Biotech and Pharma
BOS clinical Programme
BOS clinical is a new partnering conference where biotech and pharma outsourcing executives, medical and clinical programme directors can meet with CROs and other support services working in the clinical trials space.
To compliment the one to one partnering we have a varied programme of senior speakers from pharma and biotech companies who will give their insights into managing their clinical trials operations and especially their relationships to CROs and other service providers.
Our CRO showcase session will feature a number of leading companies that provide a wide range of services in helping biopharma conduct their clinical trials.
The day’s programme will be started by Dr Penelope Ward of NovImmune who will give a candid view of using single or multiple CROs in clinical trials management.
Swiss biotech Synosia Therapeutic’s Dr Uwe Meya will then give a case study showing how to accelerate the proof of concept stage. Dr Denis Mir, Senior Manager Clinical Operations with EISAI will then close the first session with a presentation on the factors to consider when choosing your CRO partner.
The Technology showcase will feature six leading CROs and give food for thought before the lunch break.
Dr Rob Williams of Cancer Research UK will start the afternoon programme discussing the particular challenges of developing anti-cancer drugs. Continuing the oncology theme, Dr Chris Beattie of Onyvax, who are developing cancer vaccines, will present a case study.
Our final presentation will take in a global view of clinical trials outsourcing and we are delighted that Dr Eric Hurden of multinational pharma company Biogen Idec will be sharing his thoughts – definitely not to be missed !
A drinks reception will close the day in the College garden where delegates can network and discuss the day’s events.
| Provisional Programme: Biotech Outsourcing Strategies 2009: BOS clinical |
|
|---|---|
| 08.00 - 09.30 | Registration and Coffee |
| 09.30 - 11.00 | Clinical Outsourcing Module (part 1)
Chaired by Kathryn Clayton, Clinical Operations Manager, Nexus Oncology |
| 09.30 - 10.00 | Single or multiple CROs for all aspects of the study set-up, management and reporting-what the pros and cons are of the sponsor managing the multiple contractors versus leaving it to the lead CRO
Dr Penelope Ward, Chief Medical Officer, NovImmune SA |
| 10.00 - 10.30 | Accelerating proof of concept go/no go through effective and smart trial design
Dr Uwe Meya, VP, Clinical Research & Development, Synosia Therapeutics |
| 10.30 - 11.00 | Early clinical development – choosing the right CRO partner
Dr Denis Mir, Clinical Project Manager , Senior Manager Clinical Operations, EISAI |
| 11.00 - 11.30 | Coffee Break & Partnering |
| 11.30 - 11.50 | Oncology Project Case studies - European metrics
Dr John Shillingford, Global Head Clinical Oprations, Averion International |
| 11.50 - 12.10 | Title TBC
Dr Peter MacLennan, Director of Project Development and Scientific Affairs, Orion Clinical Services |
| 12.10 - 12.30 | The Management of UK Clinical Research: Does one size fit all?
Dr Sarah Evans, Research Fellow, Innovation, Knowledge and Organisational Networks (IKON), University of Warwick |
| 12.30 - 14.00 | Lunch & Partnering |
| 14.00 - 15.30 | Clinical Outsourcing Module (part 2)
Chaired by Dr Chris Gardner, Director Pharma and Biotech, Citigate Dewe Rogerson |
| 14.00 - 14.30 | Considerations and challenges in the clinical development of novel anticancer drugs
Dr Rob Williams, Head of Drug Development Projects & Non Clinical Development, Cancer Research UK |
| 14.30 - 15.00 | Challenges of working with CROs, a small Biotech company perspective
Chris Beattie, Director of Clinical and Regulatory Affairs Onyvax |
| 15.00 - 15.30 | Conduct of phase I oncology studies in North America and Europe - the same but different?
Irene Gow, Director of Scientific Affairs, Nexus Oncology Ltd |
| 15.30 - 16.00 | Coffee & Partnering |
| 16.00 - 17.00 | Case Study Module
Chaired by Dr Sally Waterman, ex Director of Research & Development, Protherics |
| 16.00 - 16.45 | Strategies for success in conducting global multi-centre clinical trials: (a) Challenges and considerations when operating across international borders (b) Recruitment challenges and strategies (c) Selection and management of CRO partnerships
Dr Eric Hurden Associate Director Clinical Operations, Oncology, Biogen Idec |
| 17.00 Onwards | Drinks Reception in College Garden |
Key Sponsors
Gold CRO Sponsors
Silver CRO Sponsor
Exhibition Sponsor
Media Partner
